Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Cellular Protection and Transport of Methylated Arsenic Metabolites Differs between Human Cell Lines.

Banerjee M, Kaur G, Whitlock BD, Carew MW, Le XC, Leslie EM.

Drug Metab Dispos. 2018 Aug;46(8):1096-1105. doi: 10.1124/dmd.117.079640. Epub 2018 May 11.

PMID:
29752257
2.

Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.

Roggenbeck BA, Carew MW, Charrois GJ, Douglas DN, Kneteman NM, Lu X, Le XC, Leslie EM.

Toxicol Sci. 2015 Jun;145(2):307-20. doi: 10.1093/toxsci/kfv051. Epub 2015 Mar 9.

PMID:
25752797
3.

A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII).

Banerjee M, Carew MW, Roggenbeck BA, Whitlock BD, Naranmandura H, Le XC, Leslie EM.

Mol Pharmacol. 2014 Aug;86(2):168-79. doi: 10.1124/mol.113.091314. Epub 2014 May 28.

4.

Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.

Xu S, Zhang YF, Carew MW, Hao WH, Loo JF, Naranmandura H, Le XC.

Arch Toxicol. 2013 Jun;87(6):1013-23. doi: 10.1007/s00204-012-0956-6. Epub 2012 Oct 9.

PMID:
23052202
5.

Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1).

Carew MW, Naranmandura H, Shukalek CB, Le XC, Leslie EM.

Drug Metab Dispos. 2011 Dec;39(12):2298-304. doi: 10.1124/dmd.111.041673. Epub 2011 Sep 14.

6.

Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.

Naranmandura H, Carew MW, Xu S, Lee J, Leslie EM, Weinfeld M, Le XC.

Chem Res Toxicol. 2011 Sep 19;24(9):1586-96. doi: 10.1021/tx200291p. Epub 2011 Aug 16.

PMID:
21815631
7.

Supplemental Content

Loading ...
Support Center